4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-038452
CEO and CFO bought 2,500 shares at $7.91 ($19,775)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2023-10-25 | Purchase | +2,500 | $7.91 | $19,775 | 5,301,677 | D |
| Open-market purchases · 2,500 sh · avg $7.91 · $19,775 | |||||||
Loading xslF345X05/ownership.xml…